Chugai Pharmaceutical Co (STU:CUP) Total Tax Payable : €428 Mil (As of Jun. 2024)

View and export this data going back to . Start your Free Trial

What is Chugai Pharmaceutical Co Total Tax Payable?

Chugai Pharmaceutical Co's Total Tax Payable for the quarter that ended in Jun. 2024 was €428 Mil.

Chugai Pharmaceutical Co's quarterly Total Tax Payable declined from Dec. 2023 (€260 Mil) to Mar. 2024 (€179 Mil) but then increased from Mar. 2024 (€179 Mil) to Jun. 2024 (€428 Mil).

Chugai Pharmaceutical Co's annual Total Tax Payable increased from Dec. 2021 (€671 Mil) to Dec. 2022 (€690 Mil) but then declined from Dec. 2022 (€690 Mil) to Dec. 2023 (€260 Mil).

Chugai Pharmaceutical Co Total Tax Payable Historical Data

The historical data trend for Chugai Pharmaceutical Co's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chugai Pharmaceutical Co Total Tax Payable Chart

Chugai Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Tax Payable

Get a 7-Day Free Trial

338.61

500.28

671.04

689.51

259.84

Chugai Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Tax Payable	Get a 7-Day Free Trial															74.16	259.84	178.64	427.77	-

Chugai Pharmaceutical Co Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Chugai Pharmaceutical Co Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Chugai Pharmaceutical Co's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Chugai Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chugai Pharmaceutical Co Ltd (STU:CUP) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

CHGCY:USA CHGCF:USA 4519:Japan

Address

1-1 Nihonbashi-Muromachi 2-Chome, Nihonbashi Mitsui Tower (Reception15F), Chuo-ku, Tokyo, JPN, 103-8324

Website

http://www.chugai-pharm.co.jp

Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines. It is an industry leader in antibody technology with several flagship therapies, including Hemlibra for hemophilia A patients and tocilizumab for treating rheumatoid arthritis and covid-19 patients.

Chugai Pharmaceutical Co Headlines

No Headlines